Suchergebnisse - "Yao, Hang-Ping"

PubPharm (26)

1

MET and RON receptor tyrosine kinases in colorectal adenocarcinoma : molecular features as drug targets and antibody-drug conjugates for therapy

enthalten in: Journal of experimental & clinical cancer research : CR | 2020

von Yao, H. | Tong, X. | Hudson, R. | +1

2

Antibody-drug conjugates targeting RON receptor tyrosine kinase as a novel strategy for treatment of triple-negative breast cancer

enthalten in: Drug discovery today | 2020

von Yao, H. | Suthe, S. | Hudson, R. | +1

3

RON and MET Co-overexpression Are Significant Pathological Characteristics of Poor Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Triple-Negative Breast Cancer

enthalten in: Cancer research and treatment | 2020

von Weng, T. | Yao, M. | Xu, X. | +8

4

RON receptor tyrosine kinase in pancreatic ductal adenocarcinoma : Pathogenic mechanism in malignancy and pharmaceutical target for therapy

enthalten in: Biochimica et biophysica acta. Reviews on cancer | 2020

von Yao, H. | Hudson, R. | Wang, M.

5

Therapeutic efficacy of a novel humanized antibody-drug conjugate recognizing plexin-semaphorin-integrin domain in the RON receptor for targeted cancer therapy

enthalten in: Journal for immunotherapy of cancer | 2019

von Tong, X. | Feng, L. | Suthe, S. | +6

6

Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy

enthalten in: Journal for immunotherapy of cancer | 2019

von Yao, H. | Feng, L. | Suthe, S. | +9

ErratumIn: J Immunother Cancer. 2019 Apr 2;7(1):94. - PMID 30940188

7

RON Receptor Tyrosine Kinase as a Therapeutic Target for Eradication of Triple-Negative Breast Cancer : Efficacy of Anti-RON ADC Zt/g4-MMAE

enthalten in: Molecular cancer therapeutics | 2018

von Suthe, S. | Yao, H. | Weng, T. | +4

8

Preclinical Efficacy of Anti-RON Antibody-Drug Conjugate Zt/g4-MMAE for Targeted Therapy of Pancreatic Cancer Overexpressing RON Receptor Tyrosine Kinase

enthalten in: Molecular pharmaceutics | 2018

von Yao, H. | Feng, L. | Weng, T. | +7

9

Biological evaluation of antibody-maytansinoid conjugates as a strategy of RON targeted drug delivery for treatment of non-small cell lung cancer

enthalten in: Journal of experimental & clinical cancer research : CR | 2016

von Feng, L. | Yao, H. | Zhou, Y. | +3

ErratumIn: J Exp Clin Cancer Res. 2016;35(1):95. - PMID 27316712

10

Human tumor xenografts in mouse as a model for evaluating therapeutic efficacy of monoclonal antibodies or antibody-drug conjugate targeting receptor tyrosine kinases

enthalten in: Methods in molecular biology (Clifton, N.J.) | 2015

von Feng, L. | Wang, W. | Yao, H. | +3